News | February 20, 2025
Innocan Pharma granted first patent in India for its Liposomal CBD Injection
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
According to IQVIA, the European market for Buprenorphine-based opioid dependency treatments in 2023 surpassed USD 355 million annually
This Fast Track Designation will enable FDA to review MM-II in an expedited manner, is an important milestone in the development of MM-II
This product will be manufactured by Indoco at its manufacturing facility located at L-14, Verna Industrial Area, Verna, Goa in India
Emraclidine, a potential best-in-class, next-generation antipsychotic, is in trials designed to be registration enabling for schizophrenia
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
There is an urgent need for more therapeutic treatment options for patients with painful osteoarthritis
Breakthrough Therapy designation for pain associated with DPN granted by FDA
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Strategies aimed at solving the current overdose epidemic must go beyond the identification of risk
Subscribe To Our Newsletter & Stay Updated
